b'<?xml version="1.0" encoding="utf-8"?>\n<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">\n<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">\n    \n    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />\n        <!-- AppResources meta begin -->\n        <script type="text/javascript">var ncbi_startTime = new Date();</script>\n        <!-- AppResources meta end -->\n        \n        <!-- TemplateResources meta begin -->\n        <meta name="paf_template" content="" />\n\n        <!-- TemplateResources meta end -->\n        \n        <!-- Logger begin -->\n        <meta name="ncbi_db" content="pmc" /><meta name="ncbi_pdid" content="article" /><meta name="ncbi_acc" content="" /><meta name="ncbi_domain" content="plosone" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/articles/PMC1762349/" /><meta name="ncbi_app" content="pmc" />\n        <!-- Logger end -->\n        \n        <title>Long-Term Persistence of Robust Antibody and Cytotoxic T Cell Responses in Recovered Patients Infected with SARS Coronavirus</title>\n        \n        <!-- AppResources external_resources begin -->\n        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>\n\n        <!-- AppResources external_resources end -->\n        \n        <!-- Page meta begin -->\n        <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1762349/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="citation_journal_title" content="PLoS ONE" /><meta name="citation_title" content="Long-Term Persistence of Robust Antibody and Cytotoxic T Cell Responses in Recovered Patients Infected with SARS Coronavirus" /><meta name="citation_authors" content="Taisheng Li, Jing Xie, Yuxian He, Hongwei Fan, Laurence Baril, Zhifeng Qiu, Yang Han, Wenbing Xu, Weihong Zhang, Hui You, Yanling Zuo, Qing Fang, Jian Yu, Zhiwei Chen, Linqi Zhang" /><meta name="citation_date" content="2006" /><meta name="citation_issue" content="1" /><meta name="citation_volume" content="1" /><meta name="citation_doi" content="10.1371/journal.pone.0000024" /><meta name="citation_abstract_html_url" content="/pmc/articles/PMC1762349/?report=abstract" /><meta name="citation_pmid" content="17183651" /><meta name="DC.Title" content="Long-Term Persistence of Robust Antibody and Cytotoxic T Cell Responses in Recovered Patients Infected with SARS Coronavirus" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="Public Library of Science" /><meta name="DC.Contributor" content="Taisheng Li" /><meta name="DC.Contributor" content="Jing Xie" /><meta name="DC.Contributor" content="Yuxian He" /><meta name="DC.Contributor" content="Hongwei Fan" /><meta name="DC.Contributor" content="Laurence Baril" /><meta name="DC.Contributor" content="Zhifeng Qiu" /><meta name="DC.Contributor" content="Yang Han" /><meta name="DC.Contributor" content="Wenbing Xu" /><meta name="DC.Contributor" content="Weihong Zhang" /><meta name="DC.Contributor" content="Hui You" /><meta name="DC.Contributor" content="Yanling Zuo" /><meta name="DC.Contributor" content="Qing Fang" /><meta name="DC.Contributor" content="Jian Yu" /><meta name="DC.Contributor" content="Zhiwei Chen" /><meta name="DC.Contributor" content="Linqi Zhang" /><meta name="DC.Date" content="2006" /><meta name="DC.Identifier" content="10.1371/journal.pone.0000024" /><meta name="DC.Language" content="en" /><meta property="og:title" content="Long-Term Persistence of Robust Antibody and Cytotoxic T Cell Responses in Recovered Patients Infected with SARS Coronavirus" /><meta property="og:type" content="article" /><meta property="og:description" content="Most of the individuals infected with SARS coronavirus (SARS-CoV) spontaneously recovered without clinical intervention. However, the immunological correlates associated with patients\' recovery are currently unknown. In this report, we have sequentially ..." /><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1762349/" /><meta property="og:site_name" content="PubMed Central (PMC)" /><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbi" /><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc_extras_prnt.min.css" type="text/css" media="print" /><script type="text/javascript" src="/corehtml/pmc/js/common.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js">//</script><meta name="citationexporter" content="backend:\'https://api.ncbi.nlm.nih.gov/lit/ctxp/v1/pmc/\'" /><script type="text/javascript" src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/jquery.citationexporter.min.js">//</script><link rel="stylesheet" href="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/citationexporter.css" type="text/css" /><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-plosone.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">\n        div.pmc_para_cit li.highlight,\n        div.pmc_para_cit li.highlight .one_line_source\n        { background: #E0E0E0; }\n        a.bibr.highlight { background: #E0E0E0; } \n      </style><meta name="cited_in_systematic_reviews" content="" /><link rel="alternate" type="application/epub+zip" href="/pmc/articles/PMC1762349/epub/" /><link rel="alternate" type="application/pdf" href="/pmc/articles/PMC1762349/pdf/pone.0000024.pdf" />\n\n        <!-- Page meta end -->\n    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="8A1B5F43E99AD6E100000000003E003E.m_8" />\n<meta name=\'referrer\' content=\'origin-when-cross-origin\'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4048120/3846471/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3881636/3579733/4062871/12930/3964959/3855473/4047625/3854974/3854955/4076335/4128070/9685/3549676/3609192/3609193/3609213/3395586/4143404.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3411343/3882866/4157116.css" media="print" /></head>\n    <body class="article">\n        <div class="grid">\n            <div class="col twelve_col nomargin shadow">\n                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->\n                <div class="sysmessages">\n                    <noscript>\n\t<p class="nojs">\n\t<strong>Warning:</strong>\n\tThe NCBI web site requires JavaScript to function. \n\t<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>\n\t</p>\n\t</noscript>\n                </div>\n                <!--/.sysmessage-->\n                <div class="wrap">\n                    <div class="page">\n                        <div class="top">\n                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main\n                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to\n                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>\n                            <div class="header">\n    <div class="res_logo">\n  <h1 class="img_logo"><a href="/pmc/" class="pmc_logo offscreen">PMC</a></h1>\n  <div class="NLMLogo">\n    <a href="https://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>\n    <br />\n    <a href="https://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>\n  </div>\n</div>\n    <div class="search"><form method="get" action="/pmc/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="pmc" selected="selected" class="last" data-ac_dict="pmc-search-autocomplete">PMC</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:\'pmc-search-autocomplete\',disableUrl:\'NcbiSearchBarAutoComplCtrl\'" autocomplete="off" data-sbconfig="ds:\'no\',pjs:\'no\',afs:\'yes\'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>\n                        <a href="/pmc/advanced/">Advanced</a>\n                    </li><li>\n                        <a href="/pmc/journals/">Journal list</a>\n                    </li><li class="help">\n                        <a target="_blank" href="/books/NBK3825/">Help</a>\n                    </li></ul></div>\n</div>\n\n                            \n                            \n                        <!--<component id="Page" label="headcontent"/>-->\n                            \n                        </div>\n                        <div class="content">\n                            <!-- site messages -->\n                            <div class="container">\n    <div id="maincontent" class="content eight_col col">\n        <div class="navlink-box">\n            <ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a href="/pmc/journals/" class="navlink">Journal List</a></li><li class="archive"><a class="navlink" href="/pmc/journals/440/">PLoS One</a></li><li class="issue-page"><a class="navlink" href="/pmc/issues/140741/">v.1(1); 2006</a></li><li class="accid">PMC1762349</li></ul>\n        </div>\n\n        <!-- Journal banner -->\n        <div class="pmc-page-banner whole_rhythm"><div><img src="/corehtml/pmc/pmcgifs/logo-plosone.gif" alt="Logo of plosone" usemap="#logo-imagemap" /><map id="logo-imagemap" name="logo-imagemap"><area shape="rect" coords="0,0,438,55" alt="PLoS One" title="PLoS One" href="http://www.plosone.org/" ref="reftype=publisher&amp;article-id=1762349&amp;issue-id=140741&amp;journal-id=440&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext" /><area shape="rect" coords="0,56,104,74" alt="View this Article" title="View this Article" href="//dx.doi.org/10.1371/journal.pone.0000024" ref="reftype=publisher&amp;article-id=1762349&amp;issue-id=140741&amp;journal-id=440&amp;FROM=Article%7CBanner&amp;TO=Content%20Provider%7CArticle%7CFullText" target="pmc_ext" /><area shape="rect" coords="106,56,202,74" alt="Submit to PLoS" title="Submit to PLoS" href="http://www.plosone.org/static/checklist.action" ref="reftype=publisher&amp;article-id=1762349&amp;issue-id=140741&amp;journal-id=440&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext" /><area shape="rect" coords="204,56,302,74" alt="Get E-mail Alerts" title="Get E-mail Alerts" href="http://journals.plos.org/alerts" ref="reftype=publisher&amp;article-id=1762349&amp;issue-id=140741&amp;journal-id=440&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext" /><area shape="rect" coords="304,56,374,74" alt="Contact Us" title="Contact Us" href="http://www.plosone.org/static/contact.action" ref="reftype=publisher&amp;article-id=1762349&amp;issue-id=140741&amp;journal-id=440&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext" /><area shape="rect" coords="440,0,500,55" alt="Public Library of Science (PLoS)" title="Public Library of Science (PLoS)" href="http://www.plos.org/" ref="reftype=publisher&amp;article-id=1762349&amp;issue-id=140741&amp;journal-id=440&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext" /></map></div> </div>\n        \n        <!--component id=\'MainPortlet\' label=\'search-reference\'/-->\n        \n        <!-- Book content -->\n        <div class="">\n            \n        \n            \n            <div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: [\'h2\'], headingExclude: \':hidden\'"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="inline_block eight_col va_top"><div><div><span class="cit"><span id="pmcmata">PLoS One</span>. 2006; 1(1): e24. </span></div><div><span class="fm-vol-iss-date">Published online 2006 Dec 20. </span>  <span class="doi">doi:\xc2\xa0<a href="//dx.doi.org/10.1371%2Fjournal.pone.0000024" target="pmc_ext" ref="reftype=other&amp;article-id=1762349&amp;issue-id=140741&amp;journal-id=440&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1371/journal.pone.0000024</a></span></div></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC1762349</span></div><div class="fm-citation-pmid">PMID: <a href="/pubmed/17183651">17183651</a></div></div></div></div><h1 class="content-title">Long-Term Persistence of Robust Antibody and Cytotoxic T Cell Responses in Recovered Patients Infected with SARS Coronavirus</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="/pubmed/?term=Li%20T%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=17183651" class="affpopup" co-rid="_co_idm139853894053776" co-class="co-affbox">Taisheng Li</a>,<sup>\n1\n,</sup><sup>\n2\n,</sup><sup>\n&#x0002a;\n</sup> <a href="/pubmed/?term=Xie%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=17183651" class="affpopup" co-rid="_co_idm139853894255936" co-class="co-affbox">Jing Xie</a>,<sup>\n1\n,</sup><sup>\n2\n</sup> <a href="/pubmed/?term=He%20Y%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=17183651" class="affpopup" co-rid="_co_idm139853894252448" co-class="co-affbox">Yuxian He</a>,<sup>\n1\n,</sup><sup>\n2\n,</sup><sup>\n3\n</sup> <a href="/pubmed/?term=Fan%20H%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=17183651" class="affpopup" co-rid="_co_idm139853894247840" co-class="co-affbox">Hongwei Fan</a>,<sup>\n1\n,</sup><sup>\n2\n</sup> <a href="/pubmed/?term=Baril%20L%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=17183651" class="affpopup" co-rid="_co_idm139853933676080" co-class="co-affbox">Laurence Baril</a>,<sup>\n4\n</sup> <a href="/pubmed/?term=Qiu%20Z%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=17183651" class="affpopup" co-rid="_co_idm139853933673712" co-class="co-affbox">Zhifeng Qiu</a>,<sup>\n1\n,</sup><sup>\n2\n</sup> <a href="/pubmed/?term=Han%20Y%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=17183651" class="affpopup" co-rid="_co_idm139853933670224" co-class="co-affbox">Yang Han</a>,<sup>\n1\n,</sup><sup>\n2\n</sup> <a href="/pubmed/?term=Xu%20W%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=17183651" class="affpopup" co-rid="_co_idm139853895247216" co-class="co-affbox">Wenbing Xu</a>,<sup>\n1\n,</sup><sup>\n2\n</sup> <a href="/pubmed/?term=Zhang%20W%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=17183651" class="affpopup" co-rid="_co_idm139853895243728" co-class="co-affbox">Weihong Zhang</a>,<sup>\n1\n,</sup><sup>\n2\n</sup> <a href="/pubmed/?term=You%20H%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=17183651" class="affpopup" co-rid="_co_idm139853895240240" co-class="co-affbox">Hui You</a>,<sup>\n1\n,</sup><sup>\n2\n</sup> <a href="/pubmed/?term=Zuo%20Y%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=17183651" class="affpopup" co-rid="_co_idm139853894719888" co-class="co-affbox">Yanling Zuo</a>,<sup>\n1\n,</sup><sup>\n2\n</sup> <a href="/pubmed/?term=Fang%20Q%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=17183651" class="affpopup" co-rid="_co_idm139853894716400" co-class="co-affbox">Qing Fang</a>,<sup>\n5\n</sup> <a href="/pubmed/?term=Yu%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=17183651" class="affpopup" co-rid="_co_idm139853894714032" co-class="co-affbox">Jian Yu</a>,<sup>\n5\n</sup> <a href="/pubmed/?term=Chen%20Z%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=17183651" class="affpopup" co-rid="_co_idm139853894711664" co-class="co-affbox">Zhiwei Chen</a>,<sup>\n5\n</sup> and  <a href="/pubmed/?term=Zhang%20L%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=17183651" class="affpopup" co-rid="_co_idm139853895429584" co-class="co-affbox">Linqi Zhang</a><sup>\n1\n,</sup><sup>\n2\n,</sup><sup>\n5\n,</sup><sup>\n&#x0002a;\n</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm139853894053776"><h3 class="no_margin">Taisheng Li</h3><p>  <sup>1</sup>  Department of Infectious Disease, Peking Union Medical College Hospital and AIDS Research Center, Chinese Academy of Medical Sciences and Peking Union Medical College,   Beijing, China,   </p><p>  <sup>2</sup>  Institute of Pathogen Biology, Chinese Academy of Medical Sciences and Peking Union Medical College,   Beijing, China,   </p><div>Find articles by <a href="/pubmed/?term=Li%20T%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=17183651">Taisheng Li</a></div></div><div id="_co_idm139853894255936"><h3 class="no_margin">Jing Xie</h3><p>  <sup>1</sup>  Department of Infectious Disease, Peking Union Medical College Hospital and AIDS Research Center, Chinese Academy of Medical Sciences and Peking Union Medical College,   Beijing, China,   </p><p>  <sup>2</sup>  Institute of Pathogen Biology, Chinese Academy of Medical Sciences and Peking Union Medical College,   Beijing, China,   </p><div>Find articles by <a href="/pubmed/?term=Xie%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=17183651">Jing Xie</a></div></div><div id="_co_idm139853894252448"><h3 class="no_margin">Yuxian He</h3><p>  <sup>1</sup>  Department of Infectious Disease, Peking Union Medical College Hospital and AIDS Research Center, Chinese Academy of Medical Sciences and Peking Union Medical College,   Beijing, China,   </p><p>  <sup>2</sup>  Institute of Pathogen Biology, Chinese Academy of Medical Sciences and Peking Union Medical College,   Beijing, China,   </p><p>  <sup>3</sup>  Lindsley F. Kimball Research Institute, New York Blood Center,   New York, New York, United States of America,   </p><div>Find articles by <a href="/pubmed/?term=He%20Y%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=17183651">Yuxian He</a></div></div><div id="_co_idm139853894247840"><h3 class="no_margin">Hongwei Fan</h3><p>  <sup>1</sup>  Department of Infectious Disease, Peking Union Medical College Hospital and AIDS Research Center, Chinese Academy of Medical Sciences and Peking Union Medical College,   Beijing, China,   </p><p>  <sup>2</sup>  Institute of Pathogen Biology, Chinese Academy of Medical Sciences and Peking Union Medical College,   Beijing, China,   </p><div>Find articles by <a href="/pubmed/?term=Fan%20H%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=17183651">Hongwei Fan</a></div></div><div id="_co_idm139853933676080"><h3 class="no_margin">Laurence Baril</h3><p>  <sup>4</sup>  Emerging Diseases Epidemiology Unit, Institute Pasteur,   Paris, France,   </p><div>Find articles by <a href="/pubmed/?term=Baril%20L%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=17183651">Laurence Baril</a></div></div><div id="_co_idm139853933673712"><h3 class="no_margin">Zhifeng Qiu</h3><p>  <sup>1</sup>  Department of Infectious Disease, Peking Union Medical College Hospital and AIDS Research Center, Chinese Academy of Medical Sciences and Peking Union Medical College,   Beijing, China,   </p><p>  <sup>2</sup>  Institute of Pathogen Biology, Chinese Academy of Medical Sciences and Peking Union Medical College,   Beijing, China,   </p><div>Find articles by <a href="/pubmed/?term=Qiu%20Z%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=17183651">Zhifeng Qiu</a></div></div><div id="_co_idm139853933670224"><h3 class="no_margin">Yang Han</h3><p>  <sup>1</sup>  Department of Infectious Disease, Peking Union Medical College Hospital and AIDS Research Center, Chinese Academy of Medical Sciences and Peking Union Medical College,   Beijing, China,   </p><p>  <sup>2</sup>  Institute of Pathogen Biology, Chinese Academy of Medical Sciences and Peking Union Medical College,   Beijing, China,   </p><div>Find articles by <a href="/pubmed/?term=Han%20Y%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=17183651">Yang Han</a></div></div><div id="_co_idm139853895247216"><h3 class="no_margin">Wenbing Xu</h3><p>  <sup>1</sup>  Department of Infectious Disease, Peking Union Medical College Hospital and AIDS Research Center, Chinese Academy of Medical Sciences and Peking Union Medical College,   Beijing, China,   </p><p>  <sup>2</sup>  Institute of Pathogen Biology, Chinese Academy of Medical Sciences and Peking Union Medical College,   Beijing, China,   </p><div>Find articles by <a href="/pubmed/?term=Xu%20W%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=17183651">Wenbing Xu</a></div></div><div id="_co_idm139853895243728"><h3 class="no_margin">Weihong Zhang</h3><p>  <sup>1</sup>  Department of Infectious Disease, Peking Union Medical College Hospital and AIDS Research Center, Chinese Academy of Medical Sciences and Peking Union Medical College,   Beijing, China,   </p><p>  <sup>2</sup>  Institute of Pathogen Biology, Chinese Academy of Medical Sciences and Peking Union Medical College,   Beijing, China,   </p><div>Find articles by <a href="/pubmed/?term=Zhang%20W%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=17183651">Weihong Zhang</a></div></div><div id="_co_idm139853895240240"><h3 class="no_margin">Hui You</h3><p>  <sup>1</sup>  Department of Infectious Disease, Peking Union Medical College Hospital and AIDS Research Center, Chinese Academy of Medical Sciences and Peking Union Medical College,   Beijing, China,   </p><p>  <sup>2</sup>  Institute of Pathogen Biology, Chinese Academy of Medical Sciences and Peking Union Medical College,   Beijing, China,   </p><div>Find articles by <a href="/pubmed/?term=You%20H%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=17183651">Hui You</a></div></div><div id="_co_idm139853894719888"><h3 class="no_margin">Yanling Zuo</h3><p>  <sup>1</sup>  Department of Infectious Disease, Peking Union Medical College Hospital and AIDS Research Center, Chinese Academy of Medical Sciences and Peking Union Medical College,   Beijing, China,   </p><p>  <sup>2</sup>  Institute of Pathogen Biology, Chinese Academy of Medical Sciences and Peking Union Medical College,   Beijing, China,   </p><div>Find articles by <a href="/pubmed/?term=Zuo%20Y%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=17183651">Yanling Zuo</a></div></div><div id="_co_idm139853894716400"><h3 class="no_margin">Qing Fang</h3><p>  <sup>5</sup>  Aaron Diamond AIDS Research Center, The Rockefeller University,   New York, New York, United States of America,   </p><div>Find articles by <a href="/pubmed/?term=Fang%20Q%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=17183651">Qing Fang</a></div></div><div id="_co_idm139853894714032"><h3 class="no_margin">Jian Yu</h3><p>  <sup>5</sup>  Aaron Diamond AIDS Research Center, The Rockefeller University,   New York, New York, United States of America,   </p><div>Find articles by <a href="/pubmed/?term=Yu%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=17183651">Jian Yu</a></div></div><div id="_co_idm139853894711664"><h3 class="no_margin">Zhiwei Chen</h3><p>  <sup>5</sup>  Aaron Diamond AIDS Research Center, The Rockefeller University,   New York, New York, United States of America,   </p><div>Find articles by <a href="/pubmed/?term=Chen%20Z%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=17183651">Zhiwei Chen</a></div></div><div id="_co_idm139853895429584"><h3 class="no_margin">Linqi Zhang</h3><p>  <sup>1</sup>  Department of Infectious Disease, Peking Union Medical College Hospital and AIDS Research Center, Chinese Academy of Medical Sciences and Peking Union Medical College,   Beijing, China,   </p><p>  <sup>2</sup>  Institute of Pathogen Biology, Chinese Academy of Medical Sciences and Peking Union Medical College,   Beijing, China,   </p><p>  <sup>5</sup>  Aaron Diamond AIDS Research Center, The Rockefeller University,   New York, New York, United States of America,   </p><div>Find articles by <a href="/pubmed/?term=Zhang%20L%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=17183651">Linqi Zhang</a></div></div></div></div><div class="contrib-group half_rhythm fm-editor">Derya Unutmaz, <span class="fm-role">Academic Editor</span><sup></sup></div><div class="fm-panel half_rhythm"><div class="togglers"><a href="#" class="pmctoggle" rid="idm139853930903056_ai idm139853894053904_ai idm139853895665712_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm139853930903056_an">Article notes</a> <a href="#" class="pmctoggle" rid="idm139853930903056_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/">Disclaimer</a></div><div class="fm-authors-info fm-panel hide half_rhythm" id="idm139853930903056_ai" style="display:none"><div class="fm-affl" lang="en" id="aff1">  <sup>1</sup>  Department of Infectious Disease, Peking Union Medical College Hospital and AIDS Research Center, Chinese Academy of Medical Sciences and Peking Union Medical College,   Beijing, China,   </div><div class="fm-affl" lang="en" id="aff2">  <sup>2</sup>  Institute of Pathogen Biology, Chinese Academy of Medical Sciences and Peking Union Medical College,   Beijing, China,   </div><div class="fm-affl" lang="en" id="aff3">  <sup>3</sup>  Lindsley F. Kimball Research Institute, New York Blood Center,   New York, New York, United States of America,   </div><div class="fm-affl" lang="en" id="aff4">  <sup>4</sup>  Emerging Diseases Epidemiology Unit, Institute Pasteur,   Paris, France,   </div><div class="fm-affl" lang="en" id="aff5">  <sup>5</sup>  Aaron Diamond AIDS Research Center, The Rockefeller University,   New York, New York, United States of America,   </div><div class="fm-affl" lang="en" id="edit1">New York University School of Medicine, United States of America</div><div id="n101">&#x0002a; To whom correspondence should be addressed. E-mail: <a href="mailto:dev@null" data-email="ten.362@hstil" class="oemail">ten.362@hstil</a> (TL); <a href="mailto:dev@null" data-email="moc.liamtoh@70gnahzl" class="oemail">moc.liamtoh@70gnahzl</a> (LZ)</div><div><p id="__p1" class="p p-first-last">Conceived and designed the experiments: ZC LZ TL JX YH LB. Performed the experiments: ZC LZ QF TL JX YH HF ZQ YH WX WZ HY YZ JY. Analyzed the data: ZC LZ QF TL JX HF LB ZQ YH WX WZ HY YZ JY. Contributed reagents/materials/analysis tools: LZ. Wrote the paper: LZ</p></div></div><div class="fm-article-notes fm-panel hide half_rhythm" id="idm139853930903056_an" style="display:none"><div class="fm-pubdate half_rhythm">Received 2006 Aug 21; Accepted 2006 Sep 22.</div></div><div class="permissions fm-panel half_rhythm hide" id="idm139853930903056_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a> Li et al.</div><div class="license half_rhythm">This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.</div></div></div><div id="pmclinksbox" class="links-box whole_rhythm"><div class="fm-panel"><div>This article has been <a href="/pmc/articles/PMC1762349/citedby/">cited by</a> other articles in PMC.</div></div></div></div><div class="sec"></div><div id="idm139853896947600" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="idm139853896947600title">Abstract</h2><!--article-meta--><div><p id="__p2" class="p p-first-last">Most of the individuals infected with SARS coronavirus (SARS-CoV) spontaneously recovered without clinical intervention. However, the immunological correlates associated with patients\' recovery are currently unknown. In this report, we have sequentially monitored 30 recovered patients over a two-year period to characterize temporal changes in SARS-CoV-specific antibody responses as well as cytotoxic T cell (CTL) responses. We have found persistence of robust antibody and CTL responses in all of the study subjects throughout the study period, with a moderate decline one year after the onset of symptoms. We have also identified two potential major CTL epitopes in N proteins based on ELISPOT analysis of pooled peptides. However, despite the potent immune responses and clinical recovery, peripheral lymphocyte counts in the recovered patients have not yet been restored to normal levels. In summary, our study has, for the first time, characterized the temporal and dynamic changes of humoral and CTL responses in the natural history of SARS-recovered individuals, and strongly supports the notion that high and sustainable levels of immune responses correlate strongly with the disease outcome. Our findings have direct implications for future design and development of effective therapeutic agents and vaccines against SARS-CoV infection.</p></div></div><div id="s1" class="tsec sec"><h2 class="head no_bottom_margin" id="s1title">Introduction</h2><p id="__p3" class="p p-first-last">SARS, or severe acute respiratory syndrome, is a serious respiratory illness caused by a novel variant of coronavirus (SARS-associated coronavirus, SARS-CoV) <a href="#pone.0000024-Drosten1" rid="pone.0000024-Drosten1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_663485219">[1]</a>&#x02013;<a href="#pone.0000024-Poutanen1" rid="pone.0000024-Poutanen1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_663485225">[8]</a>. Others and we have previously demonstrated that the persistent and high levels of N protein-specific and S glycoprotein-specific neutralizing antibody (Nab) responses during the first several weeks of infection are correlated with the disease outcomes <a href="#pone.0000024-Temperton1" rid="pone.0000024-Temperton1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_663485216">[9]</a>&#x02013;<a href="#pone.0000024-Woo2" rid="pone.0000024-Woo2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_663485231">[15]</a>. However, little is known about magnitude and longevity of the both humoral and CTL responses after prolonged recovery. Studying the long-term changes in humoral and CTL responses in recovered patients will not only verify the earlier findings from short-term follow-ups but also to further establish correlates of protection to be generated by future vaccine candidates.</p></div><div id="s2" class="tsec sec"><h2 class="head no_bottom_margin" id="s2title">Results</h2><p id="__p4" class="p p-first">Starting in March 2003, we have enrolled and sequentially followed up 30 patients who were diagnosed and recovered from SARS-CoV infection according to clinical criteria released by the World Health Organization (<a href="http://www.who.int/csr/sars/casedefinition/en" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=1762349&amp;issue-id=140741&amp;journal-id=440&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://www.who.int/csr/sars/casedefinition/en</a>). Sequential blood samples were collected at 1, 3, 6, 12 and 24 months after the onset of symptoms from the enrolled patients at the Department of Infectious Diseases, Peking Union Medical College Hospital in Beijing under the guidelines of the ethical review committee at Hospital. Recovered patients were defined as those free from the acute illness (high body temperature, dry cough or light-white sputum, shortness of breath, hypoxia, and air-space consolidation in lungs) approximately 1 month after the onset of symptom with definitive sero-positivity against SARS-CoV lysates at least two consecutive occasions. Clinically, these recovered patients regain their normal body temperature, experience no cough or chest pain, and have normal chest radiograph and normal pulmonary function. The average age of these patients were 37&#x000b1;11 with 13 are being male and 17 female. All the participating patients were antibody and antigen negative for HIV-1, cytomegalovirus (CMV), and Epstein-Barr virus (EBV). For purposes of comparison, blood samples were also obtained from 70 normal healthy age matched individuals. The average age for these individuals is 39&#x000b1;10 with 36 are being male and 34 female.</p><p id="__p5">Using flow cytometry, we first studied the sequential changes in the absolute numbers of total lymphocytes, CD3, CD4, CD8 T lymphocytes, B lymphocytes and natural killer (NK) cells over the two years follow-ups and compared with that from normal healthy controls. As show in <a href="/pmc/articles/PMC1762349/figure/pone-0000024-g001/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0000024-g001" rid-ob="ob-pone-0000024-g001" co-legend-rid="lgnd_pone-0000024-g001"><span>Fig. 1</span></a>, recovered patients clearly experienced two distinct phases of cell restoration in the peripheral blood; an initial rapid phase for all the cell populations studied in the first 3 months after the onset of symptoms followed by a significant slower phase during the subsequent months. During the first 3 months, the average increase for the cell populations studied was as high as 22&#x00025; per month. The mean absolute total lymphocytes, CD3, CD4, and CD8 T lymphocytes, B lymphocytes and NK cells has increased from 1349 to 1870 cells/mm<sup>3</sup>, 1130 to 1268 cells/mm<sup>3</sup>, 511 to 591 cells/mm<sup>3</sup>, 440 to 547 cells/mm<sup>3</sup>, 120 to 152 cells/mm<sup>3</sup>, and 103 to 254 cells/mm<sup>3</sup>, respectively. The rapid phase for lymphocyte recovery is reminescinet of what had reported through the cross-sectional studies on the recovered SARS patients during the first few weeks of onset of symptom <a href="#pone.0000024-Peiris1" rid="pone.0000024-Peiris1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_848028787">[2]</a>, <a href="#pone.0000024-Tsang1" rid="pone.0000024-Tsang1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_663485218">[7]</a>, <a href="#pone.0000024-Poutanen1" rid="pone.0000024-Poutanen1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_663485224">[8]</a>, <a href="#pone.0000024-Peiris2" rid="pone.0000024-Peiris2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_848028789">[16]</a>, <a href="#pone.0000024-Li1" rid="pone.0000024-Li1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_848028786">[17]</a>. As we and others shown previously, the initial rapid phase in peripheral lymphocyte recovery usually coincided with the improving clinical condition of SARS patients <a href="#pone.0000024-Peiris1" rid="pone.0000024-Peiris1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_848028791">[2]</a>, <a href="#pone.0000024-Tsang1" rid="pone.0000024-Tsang1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_663485230">[7]</a>, <a href="#pone.0000024-Poutanen1" rid="pone.0000024-Poutanen1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_663485217">[8]</a>, <a href="#pone.0000024-Peiris2" rid="pone.0000024-Peiris2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_848028790">[16]</a>, <a href="#pone.0000024-Li1" rid="pone.0000024-Li1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_848028788">[17]</a>. After the first 3 months, however, the percent of increase dropped to 0.07&#x00025; per month and, in most cases, remained unchanged or slightly decreased from the previous time points (<a href="/pmc/articles/PMC1762349/figure/pone-0000024-g001/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0000024-g001" rid-ob="ob-pone-0000024-g001" co-legend-rid="lgnd_pone-0000024-g001"><span>Fig. 1</span></a>). Such distinct rate of lymphocyte recovery in the two phases is likely reflective of different mechanisms in lymphocyte regeneration, proliferation and distribution <em>in vivo</em>. Furthermore, with the exception for B lymphocytes, the mean absolute numbers for total lymphocytes, CD3, CD4, CD8 T lymphocytes, and NK cells at 24 months after the onset of symptom remained statistically different from that in normal healthy age-matched controls. This finding suggests that complete restoration of peripheral lymphocyte may require a longer period or peripheral lymphocyte reduction in SARS patients is permanent despite of recovery from clinical manifestation of SARS-CoV infection. Longer follow-ups of these patients will be needed to address these two possibilities.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="pone-0000024-g001" co-legend-rid="lgnd_pone-0000024-g001"><a href="/pmc/articles/PMC1762349/figure/pone-0000024-g001/" target="figure" rid-figpopup="pone-0000024-g001" rid-ob="ob-pone-0000024-g001"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139853934176032" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=1762349_pone.0000024.g001.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is pone.0000024.g001.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC1762349/bin/pone.0000024.g001.jpg" /></a></div><div id="largeobj_idm139853934176032" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC1762349/figure/pone-0000024-g001/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_pone-0000024-g001"><div><a class="figpopup" href="/pmc/articles/PMC1762349/figure/pone-0000024-g001/" target="figure" rid-figpopup="pone-0000024-g001" rid-ob="ob-pone-0000024-g001">Figure 1</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Sequential analysis of peripheral changes in total lymphocytes (LY), CD3, CD4, CD8, B cell, and NK cell counts in recovered patients over 2-year period after onset of symptom.</strong><p id="__p6">Grey stars indicate the significant differences between the recovered patients at 24 months after onset of symptom and normal healthy controls.</p><p id="__p7">Their respective <em>p</em> values are presented.</p></div></div></div><p id="__p8">To study the sequential changes in humoral responses against SARS-CoV, we used our previously published ELISA-based and pseudotyped retrovirus-based neutralization systems <a href="#pone.0000024-Zhang1" rid="pone.0000024-Zhang1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_663485223">[11]</a>. We first analyzed the temporal changes in total serum IgG specific for SARS-CoV, using a commercially available ELISA assay (No S20030004, HuaDa Comp, Beijing, China) based on purified whole virus lysates. As shown in <a href="/pmc/articles/PMC1762349/figure/pone-0000024-g002/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0000024-g002" rid-ob="ob-pone-0000024-g002" co-legend-rid="lgnd_pone-0000024-g002"><span>Fig. 2A</span></a>, there was an initial increase in total IgG from month 1 to 3 after onset of symptom followed by a gradual decrease over the ensuing period. In fact, much of the decrease was observed during month 3 to 18 after onset of symptom with no significant changes were found afterwards (<a href="/pmc/articles/PMC1762349/figure/pone-0000024-g002/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0000024-g002" rid-ob="ob-pone-0000024-g002" co-legend-rid="lgnd_pone-0000024-g002"><span>Fig. 2A</span></a>). In addition, we also characterized temporal changes in N protein-specific antibody and S glycoprotein-specific neutralizing antibody (Nab) responses in these patients. Our experiments were conducted with serum samples in two different dilutions (1/100 and 1/900) and <a href="/pmc/articles/PMC1762349/figure/pone-0000024-g002/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0000024-g002" rid-ob="ob-pone-0000024-g002" co-legend-rid="lgnd_pone-0000024-g002"><span>Fig. 2B</span></a> depicts the temporal changes in N protein-specific antibodies over the 24-month follow-up based on N protein-based ELISA. We have found that antibodies against N protein were detectable throughout the entire period of study. Within the first 6 month after onset of symptom, N protein-specific antibody remained relatively high although there is a clear trend of decrease over time, with more significant drop in titers between month 6 and 12 after onset of symptom and no dramatic changes afterwards (<a href="/pmc/articles/PMC1762349/figure/pone-0000024-g002/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0000024-g002" rid-ob="ob-pone-0000024-g002" co-legend-rid="lgnd_pone-0000024-g002"><span>Fig. 2B</span></a>). The same trend of changes in N protein-specific antibodies was also observed for experiments conducted with 1/900 dilution (<a href="/pmc/articles/PMC1762349/figure/pone-0000024-g002/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0000024-g002" rid-ob="ob-pone-0000024-g002" co-legend-rid="lgnd_pone-0000024-g002"><span>Fig. 2B</span></a>). In regard to S glycoprotein-specific Nab, we used our previously published pseudotyped retroviral system with S glycoprotein on the surface of virion and HIV-1 proteins encapsulated within <a href="#pone.0000024-Zhang1" rid="pone.0000024-Zhang1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_663485226">[11]</a>. Consistent with what have been observed for N-protein specific antibodies, high and sustainable levels of S glycoprotein-specific Nab were detected throughout the entire phase of study (<a href="/pmc/articles/PMC1762349/figure/pone-0000024-g002/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0000024-g002" rid-ob="ob-pone-0000024-g002" co-legend-rid="lgnd_pone-0000024-g002"><span>Fig. 2C</span></a>). At 1/100 dilution, all samples had potent neutralizing activities capable of neutralizing at least 60&#x00025; of input virion, with median level activities larger than 95&#x00025; (<a href="/pmc/articles/PMC1762349/figure/pone-0000024-g002/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0000024-g002" rid-ob="ob-pone-0000024-g002" co-legend-rid="lgnd_pone-0000024-g002"><span>Fig. 2C</span></a>). There is also of trend of decrease in S glycoprotein-specific Nab titer over time, but no dramatic drop was found between month 6 and 12 as was found for the N protein-specific antibodies. Lastly, the same trend of changes in S glycoprotein-specific Nab was also observed for experiments conducted with 1/900 dilution (<a href="/pmc/articles/PMC1762349/figure/pone-0000024-g002/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0000024-g002" rid-ob="ob-pone-0000024-g002" co-legend-rid="lgnd_pone-0000024-g002"><span>Fig. 2C</span></a>). It remains to be seen whether the levels of SARS-CoV-specific antibodies will remain unchanged or continuously decline after 24 months of follow-up.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="pone-0000024-g002" co-legend-rid="lgnd_pone-0000024-g002"><a href="/pmc/articles/PMC1762349/figure/pone-0000024-g002/" target="figure" rid-figpopup="pone-0000024-g002" rid-ob="ob-pone-0000024-g002"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139853895138128" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=1762349_pone.0000024.g002.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is pone.0000024.g002.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC1762349/bin/pone.0000024.g002.jpg" /></a></div><div id="largeobj_idm139853895138128" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC1762349/figure/pone-0000024-g002/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_pone-0000024-g002"><div><a class="figpopup" href="/pmc/articles/PMC1762349/figure/pone-0000024-g002/" target="figure" rid-figpopup="pone-0000024-g002" rid-ob="ob-pone-0000024-g002">Figure 2</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Sequential analysis of antibody responses against the whole viral lysates (A), N protein (B), and pseudotyped virus with S protein (C) of SARS-CoV in 30 recovered patients over 2-year period.</strong><p id="__p9">Serum samples were diluted 100- and 900-fold prior to ELISA and neutralization studies.</p><p id="__p10">Both dilutions were used to carried out experiments presented in (B) and (C), where the only 100-fold diluted serum were used for experiments presented in (A).</p><p id="__p11">The top and bottom of each rectangular box denote the 75<sup>th</sup> and 25<sup>th</sup> percentiles, respectively, with the median shown inside the box.</p><p id="__p12">Horizontal bars extending from each box represent the 90<sup>th</sup> and 10<sup>th</sup> percentiles.</p><p id="__p13">Significant differences between samples are indicated by grey stars with their respective <em>p</em> values.</p><p id="__p14">Otherwise no significance was found.</p></div></div></div><p id="__p15" class="p">To study the sequential changes in CTL responses against SARS-CoV, we used ELISPOT-based technique to quantify the number of INF-&#x003b3; releasing cells in the peripheral blood against peptide pools covering the entire N protein derived from the Urbani strain <a href="#pone.0000024-Rota1" rid="pone.0000024-Rota1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_663485227">[3]</a>. The peptide pools were made of 57 peptides which are 15&#x02013;18 amino acid residues in length overlapping by 10 amino acid residues. The peptide pools were obtained through the Biodefense and Emerging Infections Resources Repository at National Institute of Health (NIH) in the United States (<a href="http://www.beiresources.org/listing/index.cfm" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=1762349&amp;issue-id=140741&amp;journal-id=440&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://www.beiresources.org/listing/index.cfm</a>). We first studied the sequential changes in total number of INF-&#x003b3; releasing cells, expressed as Spot Forming Cell (SFC) per million PBMC, in the peripheral blood over the 18 months after onset of symptom. <a href="/pmc/articles/PMC1762349/figure/pone-0000024-g003/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0000024-g003" rid-ob="ob-pone-0000024-g003" co-legend-rid="lgnd_pone-0000024-g003"><span>Fig. 3A</span></a> shows the average number of INF-&#x003b3; releasing cells detected at month 3, 12 and 18 after onset of symptom. As observed for antibody responses, detectable levels of CTL responses were found throughout the study period, although there is a clear trend of decrease over time (<a href="/pmc/articles/PMC1762349/figure/pone-0000024-g003/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0000024-g003" rid-ob="ob-pone-0000024-g003" co-legend-rid="lgnd_pone-0000024-g003"><span>Fig. 3A</span></a>). To further identify the major epitopes recognized by the CTL, the 57 peptides were further divided into 15 peptide pools in a cross-broad fashion (NX1-7 vs. NY1-8) (<a href="/pmc/articles/PMC1762349/figure/pone-0000024-g004/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0000024-g004" rid-ob="ob-pone-0000024-g004" co-legend-rid="lgnd_pone-0000024-g004"><span>Fig. 4</span></a>, upper panel). The intensity and magnitude of CTL responses against the NX1-7 and NY1-8 peptide pools were presented as either the total number of SFC per million PBMC or the percent of samples having detectable levels of INF-&#x003b3; releasing cells (<a href="/pmc/articles/PMC1762349/figure/pone-0000024-g003/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0000024-g003" rid-ob="ob-pone-0000024-g003" co-legend-rid="lgnd_pone-0000024-g003"><span>Fig. 3B</span></a>). <a href="/pmc/articles/PMC1762349/figure/pone-0000024-g003/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0000024-g003" rid-ob="ob-pone-0000024-g003" co-legend-rid="lgnd_pone-0000024-g003"><span>Fig. 3B</span></a> summarizes results for all the samples tested and four peptide pools, namely NX4, NX6, NY6, and NY7, were found to be preferentially recognized by recovered SARS patients (<a href="/pmc/articles/PMC1762349/figure/pone-0000024-g003/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0000024-g003" rid-ob="ob-pone-0000024-g003" co-legend-rid="lgnd_pone-0000024-g003"><span>Fig. 3B</span></a>). Through the cross-broad analysis, we have found that there are potential two major CTL epitopes in the N protein. One is located within the region covered by peptides NC9568 and NC9569, and the other is covered by peptides NC9584 and NC9585 (<a href="/pmc/articles/PMC1762349/figure/pone-0000024-g004/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0000024-g004" rid-ob="ob-pone-0000024-g004" co-legend-rid="lgnd_pone-0000024-g004"><span>Fig. 4</span></a>, upper panel). Peptides NC9568 and NC9569 correspond to amino acid sequence MASGGGETALALLLLDRLNQLESKV between positions 211 and 235 in the N protein, whereas peptides NC9584 and NC9585 match the sequence of TWLTYHGAIKLDDKDPQFKDNVILL between positions 330 and 354 (<a href="/pmc/articles/PMC1762349/figure/pone-0000024-g004/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0000024-g004" rid-ob="ob-pone-0000024-g004" co-legend-rid="lgnd_pone-0000024-g004"><span>Fig. 4</span></a>, lower panel). Serotyping of MHC class I and II have found that A2, 3, 11 and 24, B51 and 60, and DR4, 9, 12, and 15, and DQ5, 6, 7, 8, and 9 are the predominant among our study population (<a href="/pmc/articles/PMC1762349/table/pone-0000024-t001/" target="table" class="fig-table-link figpopup" rid-figpopup="pone-0000024-t001" rid-ob="ob-pone-0000024-t001" co-legend-rid=""><span>Table 1</span></a>). Future work would be required to further fine mapping the actual CTL epitopes in these two regions and their association with particular serotypes of MHC class I.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="pone-0000024-g003" co-legend-rid="lgnd_pone-0000024-g003"><a href="/pmc/articles/PMC1762349/figure/pone-0000024-g003/" target="figure" rid-figpopup="pone-0000024-g003" rid-ob="ob-pone-0000024-g003"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139853896366880" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=1762349_pone.0000024.g003.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is pone.0000024.g003.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC1762349/bin/pone.0000024.g003.jpg" /></a></div><div id="largeobj_idm139853896366880" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC1762349/figure/pone-0000024-g003/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_pone-0000024-g003"><div><a class="figpopup" href="/pmc/articles/PMC1762349/figure/pone-0000024-g003/" target="figure" rid-figpopup="pone-0000024-g003" rid-ob="ob-pone-0000024-g003">Figure 3</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Sequential analysis of CTL responses against a pool of peptides derived from N protein in 30 recovered patients over 2-year period.</strong><p id="__p16">(A) The average number of spot forming cells (SFC) per million of PBMC from recovered patients at month 3, 12, and 18 post onset of symptom.</p><p id="__p17">No significant differences were found among these samples.</p><p id="__p18">The top and bottom of each rectangular box denote the 75<sup>th</sup> and 25<sup>th</sup> percentiles, respectively, with the median shown inside the box.</p><p id="__p19">Horizontal bars extending from each box represent the 90<sup>th</sup> and 10<sup>th</sup> percentiles.</p><p id="__p20">(B) The average number of SFC per million of PBMC against various pools of N protein peptides (open rectangle) and percent of PBMC samples recognizing various pools of N protein peptides (closed rectangle).</p><p id="__p21">An arbitrary line was draw at 3000 SFC per million PBMC to identify peptide pools that are preferentially recognized by the recovered patients in this cohort.</p></div></div></div><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="pone-0000024-g004" co-legend-rid="lgnd_pone-0000024-g004"><a href="/pmc/articles/PMC1762349/figure/pone-0000024-g004/" target="figure" rid-figpopup="pone-0000024-g004" rid-ob="ob-pone-0000024-g004"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139853894549184" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=1762349_pone.0000024.g004.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is pone.0000024.g004.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC1762349/bin/pone.0000024.g004.jpg" /></a></div><div id="largeobj_idm139853894549184" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC1762349/figure/pone-0000024-g004/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_pone-0000024-g004"><div><a class="figpopup" href="/pmc/articles/PMC1762349/figure/pone-0000024-g004/" target="figure" rid-figpopup="pone-0000024-g004" rid-ob="ob-pone-0000024-g004">Figure 4</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>The actual composition and cross-broad layout of each peptide pools derived from the N protein (upper panel).</strong><p id="__p22">The 57 peptides (one is not listed) were pooled into 15 groups, 7 of which (NX1-7) are listed vertically and 8 are (NY1-8) listed horizontally.</p><p id="__p23">The actual amino acid residue sequences preferentially recognized by the recovered patients are highlighted (lower panel), which correspond to residue sequences between position number 211 to 235 and 330 to 354.</p></div></div></div><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="pone-0000024-t001"><h3>Table 1</h3><!--caption a7--><div class="caption"><!--caption a8--><strong>MHC class I and II alleles and their frequency among the study population</strong></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139853894546352" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=1762349_pone.0000024.t001.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is pone.0000024.t001.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC1762349/bin/pone.0000024.t001.jpg" /></a></div><div id="largeobj_idm139853894546352" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC1762349/table/pone-0000024-t001/?report=objectonly">Open in a separate window</a></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139853894545504" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><td align="left" rowspan="1" colspan="1">A</td><td align="left" rowspan="1" colspan="1">Frequency</td><td align="left" rowspan="1" colspan="1">B</td><td align="left" rowspan="1" colspan="1">Frequency</td><td align="left" rowspan="1" colspan="1">DR</td><td align="left" rowspan="1" colspan="1">Frequency</td><td align="left" rowspan="1" colspan="1">DQ</td><td align="left" rowspan="1" colspan="1">Frequency</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">A1</td><td align="left" rowspan="1" colspan="1">2.08</td><td align="left" rowspan="1" colspan="1">B7</td><td align="left" rowspan="1" colspan="1">4.35</td><td align="left" rowspan="1" colspan="1">DR1</td><td align="left" rowspan="1" colspan="1">6.38</td><td align="left" rowspan="1" colspan="1">DQ2</td><td align="left" rowspan="1" colspan="1">4.08</td></tr><tr><td align="left" rowspan="1" colspan="1">A2</td><td align="left" rowspan="1" colspan="1">27.08</td><td align="left" rowspan="1" colspan="1">B13</td><td align="left" rowspan="1" colspan="1">6.52</td><td align="left" rowspan="1" colspan="1">DR4</td><td align="left" rowspan="1" colspan="1">12.77</td><td align="left" rowspan="1" colspan="1">DQ5</td><td align="left" rowspan="1" colspan="1">16.33</td></tr><tr><td align="left" rowspan="1" colspan="1">A3</td><td align="left" rowspan="1" colspan="1">14.58</td><td align="left" rowspan="1" colspan="1">B27</td><td align="left" rowspan="1" colspan="1">2.17</td><td align="left" rowspan="1" colspan="1">DR7</td><td align="left" rowspan="1" colspan="1">4.26</td><td align="left" rowspan="1" colspan="1">DQ6</td><td align="left" rowspan="1" colspan="1">22.45</td></tr><tr><td align="left" rowspan="1" colspan="1">A11</td><td align="left" rowspan="1" colspan="1">25.00</td><td align="left" rowspan="1" colspan="1">B35</td><td align="left" rowspan="1" colspan="1">8.70</td><td align="left" rowspan="1" colspan="1">DR8</td><td align="left" rowspan="1" colspan="1">6.38</td><td align="left" rowspan="1" colspan="1">DQ7</td><td align="left" rowspan="1" colspan="1">24.49</td></tr><tr><td align="left" rowspan="1" colspan="1">A24</td><td align="left" rowspan="1" colspan="1">12.50</td><td align="left" rowspan="1" colspan="1">B37</td><td align="left" rowspan="1" colspan="1">2.17</td><td align="left" rowspan="1" colspan="1">DR9</td><td align="left" rowspan="1" colspan="1">17.02</td><td align="left" rowspan="1" colspan="1">DQ8</td><td align="left" rowspan="1" colspan="1">12.24</td></tr><tr><td align="left" rowspan="1" colspan="1">A26</td><td align="left" rowspan="1" colspan="1">2.08</td><td align="left" rowspan="1" colspan="1">B46</td><td align="left" rowspan="1" colspan="1">8.70</td><td align="left" rowspan="1" colspan="1">DR10</td><td align="left" rowspan="1" colspan="1">2.13</td><td align="left" rowspan="1" colspan="1">DQ9</td><td align="left" rowspan="1" colspan="1">18.37</td></tr><tr><td align="left" rowspan="1" colspan="1">A29</td><td align="left" rowspan="1" colspan="1">2.08</td><td align="left" rowspan="1" colspan="1">B49</td><td align="left" rowspan="1" colspan="1">4.35</td><td align="left" rowspan="1" colspan="1">DR11</td><td align="left" rowspan="1" colspan="1">8.51</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">A30</td><td align="left" rowspan="1" colspan="1">4.17</td><td align="left" rowspan="1" colspan="1">B51</td><td align="left" rowspan="1" colspan="1">10.87</td><td align="left" rowspan="1" colspan="1">DR12</td><td align="left" rowspan="1" colspan="1">17.02</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">A31</td><td align="left" rowspan="1" colspan="1">2.08</td><td align="left" rowspan="1" colspan="1">B52</td><td align="left" rowspan="1" colspan="1">2.17</td><td align="left" rowspan="1" colspan="1">DR13</td><td align="left" rowspan="1" colspan="1">4.26</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">A33</td><td align="left" rowspan="1" colspan="1">6.25</td><td align="left" rowspan="1" colspan="1">B54</td><td align="left" rowspan="1" colspan="1">2.17</td><td align="left" rowspan="1" colspan="1">DR14</td><td align="left" rowspan="1" colspan="1">2.13</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">A203</td><td align="left" rowspan="1" colspan="1">2.08</td><td align="left" rowspan="1" colspan="1">B58</td><td align="left" rowspan="1" colspan="1">6.52</td><td align="left" rowspan="1" colspan="1">DR15</td><td align="left" rowspan="1" colspan="1">12.77</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">B60</td><td align="left" rowspan="1" colspan="1">15.22</td><td align="left" rowspan="1" colspan="1">DR16</td><td align="left" rowspan="1" colspan="1">4.26</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">B61</td><td align="left" rowspan="1" colspan="1">4.35</td><td align="left" rowspan="1" colspan="1">DR17</td><td align="left" rowspan="1" colspan="1">2.13</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">B62</td><td align="left" rowspan="1" colspan="1">8.70</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">B67</td><td align="left" rowspan="1" colspan="1">2.17</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">B75</td><td align="left" rowspan="1" colspan="1">4.35</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">B81</td><td align="left" rowspan="1" colspan="1">2.17</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">B3901</td><td align="left" rowspan="1" colspan="1">2.17</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">B5102</td><td align="left" rowspan="1" colspan="1">2.17</td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td></tr></tbody></table></div><div id="largeobj_idm139853894545504" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC1762349/table/pone-0000024-t001/?report=objectonly">Open in a separate window</a></div></div></div><div id="s3" class="tsec sec"><h2 class="head no_bottom_margin" id="s3title">Discussion</h2><p id="__p24" class="p p-first-last">In this report, we have extended our early study by sequentially monitoring 30 recovered SARS patients over a 2-year period to characterize temporal changes in humoral and CTL responses against SARS-CoV. We have shown for the first time that recovered patients have persistent and robust binding as well as neutralizing antibody and CTL responses throughout the study period with a moderate decline one year after the onset of symptoms. In particular, S glycoprotein-specific Nab responses are persistently high in the recovered patients even 24 months after onset of symptom. Such high and sustainable levels of SARS-CoV-specific immune responses in these patients are clear distinction from that found in patients who succumbed to the disease <a href="#pone.0000024-Zhang1" rid="pone.0000024-Zhang1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_663485215">[11]</a>, suggesting that antibody responses likely play an important role in determining the ultimate disease outcome of SARS-CoV infected patients. In addition, we have also identified two potential major CTL epitopes in N protein based on ELISPOT analysis of 57 peptides. Future work will be required to identify the actual epitopes in greater details. However, despite the potent immune responses and clinical recovery, peripheral lymphocyte counts in the recovered patients have not yet been restored to normal levels. This finding suggest that complete restoration of peripheral lymphocyte may require longer period of time, or the lymphocyte destruction during SARS-CoV infection is permanent and can only be repaired partially. In summary, our study has for the first time characterized the temporal and dynamic changes of humoral and CTL responses in the natural history of SARS-recovered individuals and strongly support the notion that high and sustainable levels of immune responses correlated strongly with the disease outcome. We strongly believe that our findings have direct implications for the design and development of therapeutics and vaccines against SARS-CoV infection and replication.</p></div><div id="s4" class="tsec sec"><h2 class="head no_bottom_margin" id="s4title">Materials and Methods</h2><div id="s4a" class="sec sec-first"><h3 id="s4atitle">Study subjects</h3><p id="__p25" class="p p-first-last">Thirty SARS patients were enrolled in March 2003 and have continuously followed up since then. They were diagnosed and recovered from SARS-CoV infection according to clinical criteria released by the World Health Organization (<a href="http://www.who.int/csr/sars/casedefinition/en" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=1762349&amp;issue-id=140741&amp;journal-id=440&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://www.who.int/csr/sars/casedefinition/en</a>). Sequential blood samples were collected with their informed consent and approval from the ethical review committee at the Department of Infectious Diseases, Peking Union Medical College Hospital in Beijing. The average age of these patients were 37&#x000b1;11 with 13 are being male and 17 female. For purposes of comparison, blood samples were also obtained from 70 normal healthy age matched individuals. The average age for these individuals is 39&#x000b1;10 with 36 are being male and 34 female.</p></div><div id="s4b" class="sec"><h3 id="s4btitle">Flow cytometry</h3><p id="__p26" class="p p-first-last">For flow cytometric analyses of various lymphocyte populations in the peripheral blood, we used our previously published protocols <a href="#pone.0000024-Li1" rid="pone.0000024-Li1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_848028785">[17]</a>.</p></div><div id="s4c" class="sec"><h3 id="s4ctitle">Antibody responses detected by ELISA and pseudotyped retrovirus</h3><p id="__p27" class="p p-first-last">Analysis of binding antibodies against whole SARS-CoV lysates or N protein, and S glycoprotein-specific neutralizing antibody (Nab) were conducted as previously reported <a href="#pone.0000024-Zhang1" rid="pone.0000024-Zhang1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_663485228">[11]</a>.</p></div><div id="s4d" class="sec"><h3 id="s4dtitle">ELISPOT assay</h3><p id="__p28" class="p p-first-last">ELISPOT assays were performed using a commercially available kit (Diaclone, France) according to manufacture\'s introduction. The peptide pools covering the entire N protein of the Urbani strain were used to stimulate patients\' peripheral blood mononuclear cells. The peptide pools were made of 57 peptides which are 15&#x02013;18 amino acid residues in length overlapping by 10 amino acid residues. These peptides were obtained through the Biodefense and Emerging Infections Resources Repository at National Institute of Health (NIH) in the United States (<a href="http://www.beiresources.org/listing/index.cfm" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=1762349&amp;issue-id=140741&amp;journal-id=440&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://www.beiresources.org/listing/index.cfm</a>).</p></div><div id="s4e" class="sec sec-last"><h3 id="s4etitle">Statistic analysis</h3><p id="__p29" class="p p-first-last">Student\'s <em>t</em> test analysis was used to determine the significance of the results. Values of <em>p</em>&#x02264;0.05 indicated statistical significance.</p></div></div><div id="idm139853895808368" class="tsec sec"><h2 class="head no_bottom_margin" id="idm139853895808368title">Acknowledgments</h2><div class="sec"><p id="__p30">We feel in debt to patients\' willingness to participate our study.</p></div></div><div id="idm139853895807744" class="tsec sec"><h2 class="head no_bottom_margin" id="idm139853895807744title">Footnotes</h2><!--back/fn-group--><div class="fm-sec half_rhythm small"><p class="fn sec" id="idm139853895807616"><p id="__p31" class="p p-first-last"><strong>Competing Interests: </strong>The authors have declared that no competing interests exist.</p></p><p class="fn sec" id="idm139853895806416"><p id="__p32" class="p p-first-last"><strong>Funding: </strong>This work was supported by the Chinese Ministry of Science and Technology, and partly by National Institute of Health (NIH) CIPRA-SARS Project (NIH U19 AI51915-02) and the European Commission grant EPISARS (SP22-CT-2004-511063). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH.</p></p></div></div><div id="idm139853895804928" class="tsec sec"><h2 class="head no_bottom_margin" id="idm139853895804928title">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="pone.0000024-Drosten1">1. <span class="element-citation">Drosten C, Gunther S, Preiser W, et al.  Identification of a novel coronavirus in patients with severe acute respiratory syndrome. <span><span class="ref-journal">N Engl J Med. </span>2003;<span class="ref-vol">348</span>:1967\xe2\x80\x9376.</span> [<a href="/pubmed/12690091" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1762349&amp;issue-id=140741&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=Identification+of+a+novel+coronavirus+in+patients+with+severe+acute+respiratory+syndrome.&amp;author=C+Drosten&amp;author=S+Gunther&amp;author=W+Preiser&amp;volume=348&amp;publication_year=2003&amp;pages=1967-76&amp;pmid=12690091&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1762349&amp;issue-id=140741&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0000024-Peiris1">2. <span class="element-citation">Peiris JS, Lai ST, Poon LL, et al.  Coronavirus as a possible cause of severe acute respiratory syndrome. <span><span class="ref-journal">Lancet. </span>2003;<span class="ref-vol">361</span>:1319\xe2\x80\x9325.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7112372/">PMC free article</a>]</span> [<a href="/pubmed/12711465" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1762349&amp;issue-id=140741&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Coronavirus+as+a+possible+cause+of+severe+acute+respiratory+syndrome.&amp;author=JS+Peiris&amp;author=ST+Lai&amp;author=LL+Poon&amp;volume=361&amp;publication_year=2003&amp;pages=1319-25&amp;pmid=12711465&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1762349&amp;issue-id=140741&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0000024-Rota1">3. <span class="element-citation">Rota PA, Oberste MS, Monroe SS, et al.  Characterization of a novel coronavirus associated with severe acute respiratory syndrome. <span><span class="ref-journal">Science. </span>2003;<span class="ref-vol">300</span>:1394\xe2\x80\x939.</span> [<a href="/pubmed/12730500" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1762349&amp;issue-id=140741&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=Characterization+of+a+novel+coronavirus+associated+with+severe+acute+respiratory+syndrome.&amp;author=PA+Rota&amp;author=MS+Oberste&amp;author=SS+Monroe&amp;volume=300&amp;publication_year=2003&amp;pages=1394-9&amp;pmid=12730500&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1762349&amp;issue-id=140741&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0000024-Marra1">4. <span class="element-citation">Marra MA, Jones SJ, Astell CR, et al.  The Genome sequence of the SARS-associated coronavirus. <span><span class="ref-journal">Science. </span>2003;<span class="ref-vol">300</span>:1399\xe2\x80\x93404.</span> [<a href="/pubmed/12730501" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1762349&amp;issue-id=140741&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=The+Genome+sequence+of+the+SARS-associated+coronavirus.&amp;author=MA+Marra&amp;author=SJ+Jones&amp;author=CR+Astell&amp;volume=300&amp;publication_year=2003&amp;pages=1399-404&amp;pmid=12730501&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1762349&amp;issue-id=140741&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0000024-Ksiazek1">5. <span class="element-citation">Ksiazek TG, Erdman D, Goldsmith CS, et al.  A novel coronavirus associated with severe acute respiratory syndrome. <span><span class="ref-journal">N Engl J Med. </span>2003;<span class="ref-vol">348</span>:1953\xe2\x80\x9366.</span> [<a href="/pubmed/12690092" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1762349&amp;issue-id=140741&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=A+novel+coronavirus+associated+with+severe+acute+respiratory+syndrome.&amp;author=TG+Ksiazek&amp;author=D+Erdman&amp;author=CS+Goldsmith&amp;volume=348&amp;publication_year=2003&amp;pages=1953-66&amp;pmid=12690092&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1762349&amp;issue-id=140741&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0000024-Kuiken1">6. <span class="element-citation">Kuiken T, Fouchier RA, Schutten M, et al.  Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. <span><span class="ref-journal">Lancet. </span>2003;<span class="ref-vol">362</span>:263\xe2\x80\x9370.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7112434/">PMC free article</a>]</span> [<a href="/pubmed/12892955" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1762349&amp;issue-id=140741&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Newly+discovered+coronavirus+as+the+primary+cause+of+severe+acute+respiratory+syndrome.&amp;author=T+Kuiken&amp;author=RA+Fouchier&amp;author=M+Schutten&amp;volume=362&amp;publication_year=2003&amp;pages=263-70&amp;pmid=12892955&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1762349&amp;issue-id=140741&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0000024-Tsang1">7. <span class="element-citation">Tsang KW, Ho PL, Ooi GC, et al.  A cluster of cases of severe acute respiratory syndrome in Hong Kong. <span><span class="ref-journal">N Engl J Med. </span>2003;<span class="ref-vol">348</span>:1977\xe2\x80\x9385.</span> [<a href="/pubmed/12671062" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1762349&amp;issue-id=140741&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=A+cluster+of+cases+of+severe+acute+respiratory+syndrome+in+Hong+Kong.&amp;author=KW+Tsang&amp;author=PL+Ho&amp;author=GC+Ooi&amp;volume=348&amp;publication_year=2003&amp;pages=1977-85&amp;pmid=12671062&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1762349&amp;issue-id=140741&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0000024-Poutanen1">8. <span class="element-citation">Poutanen SM, Low DE, Henry B, et al.  Identification of severe acute respiratory syndrome in Canada. <span><span class="ref-journal">N Engl J Med. </span>2003;<span class="ref-vol">348</span>:1995\xe2\x80\x932005.</span> [<a href="/pubmed/12671061" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1762349&amp;issue-id=140741&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=Identification+of+severe+acute+respiratory+syndrome+in+Canada.&amp;author=SM+Poutanen&amp;author=DE+Low&amp;author=B+Henry&amp;volume=348&amp;publication_year=2003&amp;pages=1995-2005&amp;pmid=12671061&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1762349&amp;issue-id=140741&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0000024-Temperton1">9. <span class="element-citation">Temperton NJ, Chan PK, Simmons G, et al.  Longitudinally profiling neutralizing antibody response to SARS coronavirus with pseudotypes. <span><span class="ref-journal">Emerg Infect Dis. </span>2005;<span class="ref-vol">11</span>:411\xe2\x80\x936.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3298259/">PMC free article</a>]</span> [<a href="/pubmed/15757556" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1762349&amp;issue-id=140741&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Emerg+Infect+Dis&amp;title=Longitudinally+profiling+neutralizing+antibody+response+to+SARS+coronavirus+with+pseudotypes.&amp;author=NJ+Temperton&amp;author=PK+Chan&amp;author=G+Simmons&amp;volume=11&amp;publication_year=2005&amp;pages=411-6&amp;pmid=15757556&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1762349&amp;issue-id=140741&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0000024-Nie1">10. <span class="element-citation">Nie Y, Wang G, Shi X, et al.  Neutralizing antibodies in patients with severe acute respiratory syndrome-associated coronavirus infection. <span><span class="ref-journal">J Infect Dis. </span>2004;<span class="ref-vol">190</span>:1119\xe2\x80\x9326.</span> [<a href="/pubmed/15319862" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1762349&amp;issue-id=140741&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Infect+Dis&amp;title=Neutralizing+antibodies+in+patients+with+severe+acute+respiratory+syndrome-associated+coronavirus+infection.&amp;author=Y+Nie&amp;author=G+Wang&amp;author=X+Shi&amp;volume=190&amp;publication_year=2004&amp;pages=1119-26&amp;pmid=15319862&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1762349&amp;issue-id=140741&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0000024-Zhang1">11. <span class="element-citation">Zhang L, Zhang F, Yu W, et al.  Antibody responses against SARS coronavirus are correlated with disease outcome of infected individuals. <span><span class="ref-journal">J Med Virol. </span>2006;<span class="ref-vol">78</span>:1\xe2\x80\x938.</span> [<a href="/pubmed/16299724" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1762349&amp;issue-id=140741&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Med+Virol&amp;title=Antibody+responses+against+SARS+coronavirus+are+correlated+with+disease+outcome+of+infected+individuals.&amp;author=L+Zhang&amp;author=F+Zhang&amp;author=W+Yu&amp;volume=78&amp;publication_year=2006&amp;pages=1-8&amp;pmid=16299724&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1762349&amp;issue-id=140741&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0000024-Leung1">12. <span class="element-citation">Leung DT, Tam FC, Ma CH, et al.  Antibody response of patients with severe acute respiratory syndrome (SARS) targets the viral nucleocapsid. <span><span class="ref-journal">J Infect Dis. </span>2004;<span class="ref-vol">190</span>:379\xe2\x80\x9386.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7110057/">PMC free article</a>]</span> [<a href="/pubmed/15216476" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1762349&amp;issue-id=140741&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Infect+Dis&amp;title=Antibody+response+of+patients+with+severe+acute+respiratory+syndrome+(SARS)+targets+the+viral+nucleocapsid.&amp;author=DT+Leung&amp;author=FC+Tam&amp;author=CH+Ma&amp;volume=190&amp;publication_year=2004&amp;pages=379-86&amp;pmid=15216476&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1762349&amp;issue-id=140741&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0000024-Shi1">13. <span class="element-citation">Shi Y, Wan Z, Li L, et al.  Antibody responses against SARS-coronavirus and its nucleocaspid in SARS patients. <span><span class="ref-journal">J Clin Virol. </span>2004;<span class="ref-vol">31</span>:66\xe2\x80\x938.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7129167/">PMC free article</a>]</span> [<a href="/pubmed/15288616" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1762349&amp;issue-id=140741&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Virol&amp;title=Antibody+responses+against+SARS-coronavirus+and+its+nucleocaspid+in+SARS+patients.&amp;author=Y+Shi&amp;author=Z+Wan&amp;author=L+Li&amp;volume=31&amp;publication_year=2004&amp;pages=66-8&amp;pmid=15288616&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1762349&amp;issue-id=140741&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0000024-Woo1">14. <span class="element-citation">Woo PC, Lau SK, Wong BH, et al.  Longitudinal profile of immunoglobulin G (IgG), IgM, and IgA antibodies against the severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein in patients with pneumonia due to the SARS coronavirus. <span><span class="ref-journal">Clin Diagn Lab Immunol. </span>2004;<span class="ref-vol">11</span>:665\xe2\x80\x938.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC440610/">PMC free article</a>]</span> [<a href="/pubmed/15242938" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1762349&amp;issue-id=140741&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Diagn+Lab+Immunol&amp;title=Longitudinal+profile+of+immunoglobulin+G+(IgG),+IgM,+and+IgA+antibodies+against+the+severe+acute+respiratory+syndrome+(SARS)+coronavirus+nucleocapsid+protein+in+patients+with+pneumonia+due+to+the+SARS+coronavirus.&amp;author=PC+Woo&amp;author=SK+Lau&amp;author=BH+Wong&amp;volume=11&amp;publication_year=2004&amp;pages=665-8&amp;pmid=15242938&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1762349&amp;issue-id=140741&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0000024-Woo2">15. <span class="element-citation">Woo PC, Lau SK, Wong BH, et al.  Detection of specific antibodies to severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein for serodiagnosis of SARS coronavirus pneumonia. <span><span class="ref-journal">J Clin Microbiol. </span>2004;<span class="ref-vol">42</span>:2306\xe2\x80\x939.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC404667/">PMC free article</a>]</span> [<a href="/pubmed/15131220" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1762349&amp;issue-id=140741&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Microbiol&amp;title=Detection+of+specific+antibodies+to+severe+acute+respiratory+syndrome+(SARS)+coronavirus+nucleocapsid+protein+for+serodiagnosis+of+SARS+coronavirus+pneumonia.&amp;author=PC+Woo&amp;author=SK+Lau&amp;author=BH+Wong&amp;volume=42&amp;publication_year=2004&amp;pages=2306-9&amp;pmid=15131220&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1762349&amp;issue-id=140741&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0000024-Peiris2">16. <span class="element-citation">Peiris J, Chu CM, Cheng V, et al.  Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. <span><span class="ref-journal">The Lancet. </span>2003;<span class="ref-vol">361</span>:1767\xe2\x80\x931772.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7112410/">PMC free article</a>]</span> [<a href="/pubmed/12781535" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1762349&amp;issue-id=140741&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=The+Lancet&amp;title=Clinical+progression+and+viral+load+in+a+community+outbreak+of+coronavirus-associated+SARS+pneumonia:+a+prospective+study.&amp;author=J+Peiris&amp;author=CM+Chu&amp;author=V+Cheng&amp;volume=361&amp;publication_year=2003&amp;pages=1767-1772&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1762349&amp;issue-id=140741&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0000024-Li1">17. <span class="element-citation">Li T, Qiu Z, Zhang L, et al.  Significant changes of peripheral T lymphocyte subsets in patients with severe acute respiratory syndrome. <span><span class="ref-journal">J Infect Dis. </span>2004;<span class="ref-vol">189</span>:648\xe2\x80\x9351.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7109946/">PMC free article</a>]</span> [<a href="/pubmed/14767818" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1762349&amp;issue-id=140741&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Infect+Dis&amp;title=Significant+changes+of+peripheral+T+lymphocyte+subsets+in+patients+with+severe+acute+respiratory+syndrome.&amp;author=T+Li&amp;author=Z+Qiu&amp;author=L+Zhang&amp;volume=189&amp;publication_year=2004&amp;pages=648-51&amp;pmid=14767818&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1762349&amp;issue-id=140741&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div></div></div></div><!--post-content--><div class="courtesy-note whole_rhythm small"><hr />Articles from <span class="acknowledgment-journal-title">PLoS ONE</span> are provided here courtesy of <strong>Public Library of Science</strong></div></div>\n            \n            \n        \n            \n        </div>\n        <!-- Book content -->\n    </div>\n    \n    <div id="rightcolumn" class="four_col col last">\n        <!-- Custom content above discovery portlets -->\n        <div class="col6">\n            \n        </div>\n        \n        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="/pmc/articles/PMC1762349/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="/pmc/articles/PMC1762349/epub/">ePub (beta)</a></li> | <li><a href="/pmc/articles/PMC1762349/pdf/pone.0000024.pdf">PDF (360K)</a></li> | <li><a href="#" data-citationid="PMC1762349" class="citationexporter ctxp">Citation</a></li></ul></div></div><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"><h2>Share</h2><ul><li class="facebook"><a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1762349%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626" alt="Share on Facebook" />\n                             Facebook\n                        </a></li><li class="twitter"><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1762349%2F&amp;text=Long-Term%20Persistence%20of%20Robust%20Antibody%20and%20Cytotoxic%20T%20Cell%20Responses%20in%20Recovered%20Patients%20Infected%20with%20SARS%20Coronavirus"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627" alt="Share on Twitter" />\n                             Twitter\n                        </a></li><li class="gplus"><a href="https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1762349%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628" alt="Share on Google Plus" />\n                             Google+\n                        </a></li></ul></div>\n        \n        <div id="ajax-portlets" data-pmid="17183651" data-aiid="1762349" data-aid="1762349" data-iid="140741" data-domainid="440" data-domain="plosone" data-accid="PMC1762349" data-md5="9529ba7cfa33c4faee917e5e9cef8a71"></div>\n                \n        <!-- Custom content below discovery portlets -->\n        <div class="col7">\n            \n        </div>\n    </div>\n</div>\n\n<!-- Custom content after all -->\n<div class="col8">\n    \n</div>\n<div class="col9">\n    \n</div>\n\n<script src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>\n<script>\n    (function($){\n        $(\'.skiplink\').each(function(i, item){\n            var href = $($(item).attr(\'href\'));\n            href.attr(\'tabindex\', \'-1\').addClass(\'skiptarget\'); // ensure the target can receive focus\n            $(item).on(\'click\', function(event){\n                event.preventDefault();\n                $.scrollTo(href, 0, {\n                    onAfter: function(){\n                        href.focus();\n                    }\n                });\n            });\n        });\n    })(jQuery);\n</script>\n\n\n\n<div id="body-link-poppers"></div>\n                        </div>\n                        <div class="bottom">\n                            \n                            <div id="NCBIFooter_dynamic">\n    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>\n    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2020-04-17T09:23:16-04:00&amp;Snapshot=%2Fprojects%2FPMC%2FPMCViewer@4.46&amp;Host=ptpmc102&amp;ncbi_phid=8A1B5F43E99AD6E100000000003E003E&amp;ncbi_session=8A1B5F43E99ADC41_0062SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1762349%2F&amp;Db=pmc&amp;folderID=132&amp;Ncbi_App=pmc&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>\n    \n</div>\n\n                            <div class="footer" id="footer">\n    \n    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>\n    <div id="external-disclaimer" class="offscreen_noflow">\n        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.\n    </div>    \n    <div id="ncbifooter" class="contact_info">      \n        <div id="footer-contents-right">\n            <div id="nlm_thumb_logo">\n                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>\n            </div>\n            <div id="nih_thumb_logo">\n                <a href="https://www.nih.gov" title="NIH">NIH</a>\n            </div>\n            <div id="hhs_thumb_logo">\n                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>\n            </div>\n            <div id="usagov_thumb_logo">\n                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>\n            </div>         \n        </div>\n        \n        <div id="footer-contents-left">\n            <p class="address vcard">\n                <span class="url">\n                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for\n                        Biotechnology Information</a>,\n                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>\n                <span class="adr">\n                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>\n                    <span class="region">MD</span>, <span class="postal-code">20894</span>\n                    <span class="country-name">USA</span>\n                </span>\n            </p>\n            \n            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>\n        </div>\n    </div>\n    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    \n    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>\n</div>\n                        </div>\n                    </div>\n                    <!--/.page-->\n                </div>\n                <!--/.wrap-->\n            </div><!-- /.twelve_col -->\n        </div>\n        <!-- /.grid -->\n\n        <span class="PAFAppResources"></span>\n        \n        <!-- BESelector tab -->\n        \n        \n        \n        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=pmc&amp;ncbi_pdid=article&amp;ncbi_acc=&amp;ncbi_domain=plosone&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/articles/PMC1762349/&amp;ncbi_app=pmc" /></noscript>\n        \n        \n        <!-- usually for JS scripts at page bottom -->\n        <!--<component id="PageFixtures" label="styles"></component>-->\n    \n\n<!-- 8A1B5F43E99ADC41_0062SID /projects/PMC/PMCViewer@4.46 ptpmc102 v4.1.r585844 Mon, May 06 2019 02:53:16 -->\n\n<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/js/3879255/4121861/3818874/4168176/3821238/4117325/4087685/4072593/4076480/3921943/4105668/4065628.js" snapshot="pmc"></script></body>\n</html>'